Yubo International Biotech annual free cash flow
2020
2021
2022
2023
Yubo International Biotech Free Cash Flow (FCF) History (YBGJ)
Yubo International Biotech reported −$738,971 in free cash flow for fiscal 2023, a decrease of $138,018 from the previous fiscal year, with a free cash flow margin of −122.21%.
View full Yubo International Biotech company overviewYubo International Biotech free cash flow by year
| Fiscal year | Period ended | Free cash flow | Change | Growth | FCF margin |
|---|---|---|---|---|---|
| 2023 | 2023-12-31 | −$738,971 | −$138,018 | — | −122.21% |
| 2022 | 2022-12-31 | −$600,953 | $984,626 | — | −576.27% |
| 2021 | 2021-12-31 | −$1.6M | −$1.6M | — | −127.42% |
| 2020 · Dec 31 | 2020-12-31 | $58,551 | — | — | — |
Yubo International Biotech quarterly free cash flow
Q1.20
Q1.21
Q2.21
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q1.25
Q1.26
| Fiscal quarter | Period ended | Free cash flow | Change | YoY growth | FCF margin |
|---|---|---|---|---|---|
| Q1 2026 | 2026-03-31 | −$207,157 | $191,072 | — | — |
| Q1 2025 | 2025-03-31 | −$398,229 | −$48,703 | — | — |
| Q1 2024 | 2024-03-31 | −$349,526 | −$316,857 | — | −10020.81% |
| Q4 2023 | 2023-12-31 | −$558,353 | $131,178 | — | −3081.25% |
| Q3 2023 | 2023-09-30 | $5,076 | −$50,160 | −90.81% | +1.18% |
| Q2 2023 | 2023-06-30 | −$153,025 | −$125,786 | — | −10701.05% |
| Q1 2023 | 2023-03-31 | −$32,669 | −$74,028 | — | −20.86% |
| Q4 2022 | 2022-12-31 | −$689,531 | −$607,808 | — | −1036.58% |
| Q3 2022 | 2022-09-30 | $55,236 | $126,270 | — | +378.85% |
| Q2 2022 | 2022-06-30 | −$27,239 | $31,866 | — | −341.77% |
| Q1 2022 | 2022-03-31 | $41,359 | $1.5M | — | +271.87% |
| Q4 2021 | 2021-12-31 | −$81,723 | — | — | — |
| Q3 2021 · Sep 30 | 2021-09-30 | −$71,034 | $65,312 | — | −72.26% |
| Q2 2021 · Jun 30 | 2021-06-30 | −$59,105 | −$259,864 | — | — |
| Q1 2021 · Mar 31 | 2021-03-31 | −$1.5M | −$914,260 | — | — |
| Q2 2021 · Sep 30 | 2020-09-30 | −$136,346 | — | — | — |
| Q1 2021 · Jun 30 | 2020-06-30 | $200,759 | — | — | — |
| Q1 2020 · Mar 31 | 2020-03-31 | −$539,873 | — | — | — |
Yubo International Biotech free cash flow growth trends
Yubo International Biotech's latest reported quarter, Q1 2026, generated −$207,157 in free cash flow, an increase of $191,072 year over year.
About the metric
What free cash flow means
Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.
Calculation and source
How free cash flow is calculated
TickerStat calculates free cash flow as reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.
Review Yubo International Biotech source filings ↗